Advanced in Thrombocytopenia

Noppacharn Uaprasert

Bangkok, TH 
Advanced in Thrombocytopenia
Bangkok, TH 
OverviewLocationsClinical Research

Overview

Noppacharn Uaprasert practices in Bangkok, Thailand. Uaprasert is rated as an Advanced expert by MediFind in the treatment of Thrombocytopenia. Their top areas of expertise are Protein S Deficiency, Protein C Deficiency, Thalassemia, and Hemoglobin E Disease.

Their clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Thrombocytopenia.

Locations

Bangkok, 10330, Thailand
Other Locations
Thailand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multi-Center, Open-Label, Two-Period Cross-Over, Patient-Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Iron Chelating Activity of DST-0509 (Deferasirox) Tablets in Thalassemia Patients With Inadequate Response to Standard Chelation Therapy
A Multi-Center, Open-Label, Two-Period Cross-Over, Patient-Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Iron Chelating Activity of DST-0509 (Deferasirox) Tablets in Thalassemia Patients With Inadequate Response to Standard Chelation Therapy
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Drug
Study Drugs: DST-0509 Iron Chelator, Jadenu, Exjade
Study Phase: Phase 2

47 Total Publications

Effects of primary granulocyte colony-stimulating factor (G-CSF) prophylaxis for chemotherapy-induced febrile neutropenia in diffuse large B-cell lymphoma patients receiving the R-CHOP-21 regimen.
Effects of primary granulocyte colony-stimulating factor (G-CSF) prophylaxis for chemotherapy-induced febrile neutropenia in diffuse large B-cell lymphoma patients receiving the R-CHOP-21 regimen.
Journal: Asian biomedicine : research, reviews and news
Published: September 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Uaprasert's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile